Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Norian begins trial of Norian SRS in hip fractures

Jan. 2, 1997

Osiris provides funds for clinical trial of hMSCs

Jan. 2, 1997

Novo Nordisk clear to market hGH product in U.S.

Jan. 2, 1997

Crinone efficacy equal to that of higher doses of oral progesterone in IVF procedures

Jan. 2, 1997

Hyperprolactinemia Rx approved by FDA

Dec. 31, 1996

Nutropin cleared for marketing

Dec. 31, 1996

Pharmagenesis forms Chinese joint venture

Dec. 31, 1996

German launch for bisphosphonate

Dec. 31, 1996

Positive phase III results reported for Ergoset monotherapy

Dec. 24, 1996

Androsorb cleared for clinical trials

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...